rs139802143

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_001123385.2(BCOR):​c.408C>T​(p.Ala136Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000467 in 1,208,860 control chromosomes in the GnomAD database, including 3 homozygotes. There are 151 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0024 ( 1 hom., 75 hem., cov: 22)
Exomes 𝑓: 0.00027 ( 2 hom. 76 hem. )

Consequence

BCOR
NM_001123385.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.175

Publications

0 publications found
Variant links:
Genes affected
BCOR (HGNC:20893): (BCL6 corepressor) The protein encoded by this gene was identified as an interacting corepressor of BCL6, a POZ/zinc finger transcription repressor that is required for germinal center formation and may influence apoptosis. This protein selectively interacts with the POZ domain of BCL6, but not with eight other POZ proteins. Specific class I and II histone deacetylases (HDACs) have been shown to interact with this protein, which suggests a possible link between the two classes of HDACs. Several transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome Y.[provided by RefSeq, Jun 2010]
BCOR Gene-Disease associations (from GenCC):
  • microphthalmia, syndromic 2
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, ClinGen, Illumina, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • microphthalmia, Lenz type
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant X-40074938-G-A is Benign according to our data. Variant chrX-40074938-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210521.
BP7
Synonymous conserved (PhyloP=0.175 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00242 (268/110710) while in subpopulation AFR AF = 0.00848 (258/30430). AF 95% confidence interval is 0.00763. There are 1 homozygotes in GnomAd4. There are 75 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 75 XL,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCORNM_001123385.2 linkc.408C>T p.Ala136Ala synonymous_variant Exon 4 of 15 ENST00000378444.9 NP_001116857.1 Q6W2J9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCORENST00000378444.9 linkc.408C>T p.Ala136Ala synonymous_variant Exon 4 of 15 1 NM_001123385.2 ENSP00000367705.4 Q6W2J9-1

Frequencies

GnomAD3 genomes
AF:
0.00242
AC:
268
AN:
110657
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00850
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000667
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.00135
GnomAD2 exomes
AF:
0.000730
AC:
134
AN:
183444
AF XY:
0.000619
show subpopulations
Gnomad AFR exome
AF:
0.00950
Gnomad AMR exome
AF:
0.000255
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000270
AC:
296
AN:
1098150
Hom.:
2
Cov.:
35
AF XY:
0.000209
AC XY:
76
AN XY:
363506
show subpopulations
African (AFR)
AF:
0.00939
AC:
248
AN:
26400
American (AMR)
AF:
0.000256
AC:
9
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30206
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
54140
European-Finnish (FIN)
AF:
0.0000740
AC:
3
AN:
40522
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4136
European-Non Finnish (NFE)
AF:
0.00000594
AC:
5
AN:
842063
Other (OTH)
AF:
0.000477
AC:
22
AN:
46091
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00242
AC:
268
AN:
110710
Hom.:
1
Cov.:
22
AF XY:
0.00228
AC XY:
75
AN XY:
32948
show subpopulations
African (AFR)
AF:
0.00848
AC:
258
AN:
30430
American (AMR)
AF:
0.000667
AC:
7
AN:
10501
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2635
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3520
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2514
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5915
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.0000189
AC:
1
AN:
52791
Other (OTH)
AF:
0.00133
AC:
2
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00135
Hom.:
3
Bravo
AF:
0.00287

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Oct 08, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

History of neurodevelopmental disorder Benign:1
Nov 01, 2011
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Oculofaciocardiodental syndrome Benign:1
Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.15
DANN
Benign
0.59
PhyloP100
0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139802143; hg19: chrX-39934191; API